134 related articles for article (PubMed ID: 29330851)
1. A case of xeroderma pigmentosum complementation group C with diverse clinical features.
Masaki T; Nakano E; Okamura K; Ono R; Sugasawa K; Lee MH; Suzuki T; Nishigori C
Br J Dermatol; 2018 Jun; 178(6):1451-1452. PubMed ID: 29330851
[No Abstract] [Full Text] [Related]
2. Renal leiomyosarcoma associated with xeroderma pigmentosum.
Tomás M; Salinas AS; Moreno J; Server G
Arch Esp Urol; 1989 Jun; 42(5):484-6. PubMed ID: 2817979
[TBL] [Abstract][Full Text] [Related]
3. Xeroderma pigmentosum group D patient bearing lentigo maligna without neurological symptoms.
Fukuro S; Yamaguchi J; Mamada A; Kondo S; Satoh Y
Dermatologica; 1990; 181(2):129-33. PubMed ID: 2242781
[TBL] [Abstract][Full Text] [Related]
4. Xeroderma pigmentosum group C in a French Caucasian patient with multiple melanoma and unusual long-term survival.
Jacobelli S; Soufir N; Lacapere JJ; Regnier S; Bourillon A; Grandchamp B; Hétet G; Pham D; Palangie A; Avril MF; Dupin N; Sarasin A; Gorin I
Br J Dermatol; 2008 Sep; 159(4):968-73. PubMed ID: 18717677
[TBL] [Abstract][Full Text] [Related]
5. The molecular basis of xeroderma pigmentosum.
Copeland NE; Hanke CW; Michalak JA
Dermatol Surg; 1997 Jun; 23(6):447-55. PubMed ID: 9217796
[TBL] [Abstract][Full Text] [Related]
6. [Xeroderma pigmentosum: review of clinical aspects, histology, etiopathogenesis and therapy (apropos of a clinical case)].
Romagnolo J; Lemaitre A; Linker M
Acta Stomatol Belg; 1983; 80(2):101-20. PubMed ID: 6576624
[No Abstract] [Full Text] [Related]
7. Xeroderma pigmentosum.
Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
[TBL] [Abstract][Full Text] [Related]
8. Severe Facial-Disfiguring Xeroderma Pigmentosum With Rapidly Progressing Malignant Tumors.
Zan T; Huang X; Li Q
JAMA Otolaryngol Head Neck Surg; 2019 Feb; 145(2):185-186. PubMed ID: 30543363
[No Abstract] [Full Text] [Related]
9. Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C.
Zeng L; Quilliet X; Chevallier-Lagente O; Eveno E; Sarasin A; Mezzina M
Gene Ther; 1997 Oct; 4(10):1077-84. PubMed ID: 9415314
[TBL] [Abstract][Full Text] [Related]
10. Oral medicine case book 60: Xeroderma pigmentosum.
Bunn BK; Botha SJ; Rajbaran S; Van Heerden WF
SADJ; 2014 Jun; 69(5):226-8. PubMed ID: 26548191
[No Abstract] [Full Text] [Related]
11. Clinical and genetic study of xeroderma pigmentosum.
al Rubaie SM; el Darouti MA
Int J Dermatol; 1990 Mar; 29(2):126-8. PubMed ID: 2323866
[TBL] [Abstract][Full Text] [Related]
12. Xeroderma pigmentosum in South Africa: Evidence for a prevalent founder effect.
Kgokolo M; Morice-Picard F; Rezvani HR; Austerlitz F; Cartault F; Sarasin A; Sathekge M; Taieb A; Ged C
Br J Dermatol; 2019 Nov; 181(5):1070-1072. PubMed ID: 31017654
[No Abstract] [Full Text] [Related]
13. [Multiple melanoma in xeroderma pigmentosum].
Fölster-Holst R; Schubert C; Christophers E
Hautarzt; 1994 Aug; 45(8):554-61. PubMed ID: 7960757
[TBL] [Abstract][Full Text] [Related]
14. [Xeroderma pigmentosum].
Takeuchi S
Nihon Rinsho; 2000 Jul; 58(7):1496-500. PubMed ID: 10921330
[TBL] [Abstract][Full Text] [Related]
15. Clinical, cellular, and molecular features of an Israeli xeroderma pigmentosum family with a frameshift mutation in the XPC gene: sun protection prolongs life.
Slor H; Batko S; Khan SG; Sobe T; Emmert S; Khadavi A; Frumkin A; Busch DB; Albert RB; Kraemer KH
J Invest Dermatol; 2000 Dec; 115(6):974-80. PubMed ID: 11121128
[TBL] [Abstract][Full Text] [Related]
16. Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients.
Emmert S; Slor H; Busch DB; Batko S; Albert RB; Coleman D; Khan SG; Abu-Libdeh B; DiGiovanna JJ; Cunningham BB; Lee MM; Crollick J; Inui H; Ueda T; Hedayati M; Grossman L; Shahlavi T; Cleaver JE; Kraemer KH
J Invest Dermatol; 2002 Jun; 118(6):972-82. PubMed ID: 12060391
[TBL] [Abstract][Full Text] [Related]
17. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
[TBL] [Abstract][Full Text] [Related]
18. A novel complex insertion/deletion mutation in the XPC DNA repair gene leads to skin cancer in an Iraqi family.
Emmert S; Wetzig T; Imoto K; Khan SG; Oh KS; Laspe P; Zachmann K; Simon JC; Kraemer KH
J Invest Dermatol; 2006 Nov; 126(11):2542-4. PubMed ID: 16794584
[No Abstract] [Full Text] [Related]
19. A noncancerous variant of xeroderma pigmentosum type D associated with novel heterozygous missense ERCC2 gene mutation.
Choudhary S; Parakh M; Suthar K; Parakh P; Khichar S
Indian J Dermatol Venereol Leprol; 2017; 83(5):594-595. PubMed ID: 28749383
[No Abstract] [Full Text] [Related]
20. [Variant-type xeroderma pigmentosum].
Oliel V; Guillot B; Sciola JP; Guilhou JJ; Meynadier J
Ann Dermatol Venereol; 1986; 113(2):143-6. PubMed ID: 3717865
[No Abstract] [Full Text] [Related]
[Next] [New Search]
